CLINICAL CHARACTERISTICS AND OUTCOMES OF MYELODYSPLASTIC NEOPLASMS AND ACUTE MYELOID LEUKEMIA WITH MECOM REARRANGEMENT: RESULTS FROM A NATIONWIDE MULTICENTER STUDY.
Introduction: “AML with MECOM rearrangement” was recently categorized by WHO classification 2022 regardless of blast count, which included those present with MDS and AML into this group. We aim to explore frequency, clinical characteristics, and outcomes in this subtype among Thai myeloid neoplasms....
Main Authors: | C. Polprasert, C. Chanswangphuwana, W. Owattanapanich, S. Kungwankiattichai, E. Rattarittamrong, T. Rattanathammethee, A. Tantiworawit, W. Limvorapitak, S. Saengboon, P. Niparuck, T. Puavilai, J. Julamanee, P. Saelue, C. Wanitpongpun, C. Nakhakes, K. Prayongratana, E. Karoopongse, P. Rojnuckarin, C. Sriswasdi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Leukemia Research Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048924000104 |
Similar Items
-
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG
by: Smith Kungwankiattichai, et al.
Published: (2023-12-01) -
Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms
by: Chantana Polprasert, et al.
Published: (2022-12-01) -
External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival
by: Naree Warnnissorn, et al.
Published: (2022-12-01) -
Epigenetic landscape reveals MECOM as an endothelial lineage regulator
by: Jie Lv, et al.
Published: (2023-04-01) -
MECOM promotes supporting cell proliferation and differentiation in cochlea
by: Peipei Chen, et al.
Published: (2022-04-01)